Literature DB >> 22628360

PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon.

Saskia M J Hopman1, Rick R Van Rijn, Charis Eng, Johannes Bras, Marielle Alders, Chantal M van der Horst, Raoul C M Hennekam, Johannes H M Merks.   

Abstract

PTEN: hamartoma tumor syndrome (PHTS) is a group of syndromes caused by mutations in PTEN. Gorham-Stout phenomenon (GSP) is a rare condition characterized by proliferation of vascular structures in bones, resulting in progressive osteolysis. Here we present a 1-year-old boy with PHTS and GSP. The lesion that later proved to be GSP was evident from the age of 4 months, and became symptomatic at the age of 1 year. Eventually, he developed a fatal chylothorax. Mutation analysis revealed a germline heterozygous mutation c.517 C>T (p.Arg173Cys) in exon 6 of PTEN. Analysis of the lymphatic malformation (LM) tissue revealed no loss of heterozygosity (LOH) nor a second, somatic PTEN mutation of the remaining wild type allele. The germline p.Arg173Cys mutation was also present in the mother and the propositus' younger sister and brother. Further molecular work-up showed a heterozygous variant c.2180C>T (p.Ala727Val) FLT4 in the LM tissue, which was also present in the germline of mother and two siblings. GSP has not been reported before in a patient with a PTEN mutation. Up to this date, this mutation is the only genetic defect possibly involved in the etiology of GSP which is plausible given the known function of PTEN in angiogenic signaling.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628360     DOI: 10.1002/ajmg.a.35406

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  PTEN hamartoma of the soft tissue: the initial manifestation of an underlying PTEN hamartoma tumor syndrome in a 4-year-old female.

Authors:  Charles B Chism; Lindsay Crawford; Amanda Tchakarov; Alyaa Al-Ibraheemi; Nicholas M Beckmann
Journal:  Skeletal Radiol       Date:  2017-07-29       Impact factor: 2.199

2.  Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease.

Authors:  Marcos Yébenes Mayordomo; Sofian Al Shboul; Maria Gómez-Herranz; Asim Azfer; Alison Meynert; Donald Salter; Larry Hayward; Anca Oniscu; James T Patton; Ted Hupp; Mark J Arends; Javier Antonio Alfaro
Journal:  BMC Med Genomics       Date:  2022-06-06       Impact factor: 3.622

3.  Primary versus trauma-induced Gorham-Stout disease.

Authors:  N Tanoue; L Moedano; M Witte; M Montague; A Lukefahr; M Bernas
Journal:  Lymphology       Date:  2018       Impact factor: 1.286

4.  Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature.

Authors:  Yi Liu; Ding-Rong Zhong; Pei-Ran Zhou; Fang Lv; Dou-Dou Ma; Wei-Bo Xia; Yan Jiang; Ou Wang; Xiao-Ping Xing; Mei Li
Journal:  Clin Rheumatol       Date:  2014-09-18       Impact factor: 2.980

5.  Left Functional Pneumonectomy Caused by a Very Rare Giant Intrathoracic Cystic Lesion in a Patient with Gorham-Stout Syndrome: Case Report and Review of the Literature.

Authors:  Nikolaos Tasis; Ioannis Tsouknidas; Argyrios Ioannidis; Konstantinos Nassiopoulos; Dimitrios Filippou
Journal:  Case Rep Pulmonol       Date:  2018-04-12

Review 6.  Current concepts from diagnosis to management in Gorham-Stout disease: a systematic narrative review of about 350 cases.

Authors:  Andrea Angelini; Nicolò Mosele; Elisa Pagliarini; Pietro Ruggieri
Journal:  EFORT Open Rev       Date:  2022-01-11

7.  Thyroid involvement in two patients with Bannayan-Riley-Ruvalcaba syndrome.

Authors:  Valentina Peiretti; Alessandro Mussa; Francesca Feyles; Gerdi Tuli; Arianna Santanera; Cristina Molinatto; Giovanni Battista Ferrero; Andrea Corrias
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.